Ovoca Bio to Transition into Mineral Exploration with Acquisition of Tadeen International
By
Fiona Craig
PUBLISHED:
May 07 2025 @ 02:57
|
Comments (0)
|
More info about Fiona Craig
Ovoca Bio PLC (LSE:OVB) has announced a major strategic pivot through a proposed acquisition of Tadeen International Limited, a company that holds mineral exploration licenses in Morocco. The move signals Ovoca’s departure from its biopharmaceutical roots as it shifts focus toward the resource sector. This transformation will be executed via a reverse takeover, which is subject to shareholder approval and a re-admission process to AIM.
As part of the restructuring, Ovoca plans to rebrand with a new name that better reflects its mineral exploration ambitions. The company also intends to delist from Euronext Growth, opting to concentrate its trading activity exclusively on AIM. This consolidation is expected to streamline operations and cut administrative expenses.
About the Company (Soon to be Renamed Ovoca Gold)
Ovoca Bio, historically centered on developing treatments in the biopharma space, is now reorienting its business model toward the natural resources sector. Through the acquisition of Tadeen International, it gains access to promising mineral assets in Morocco—marking a bold redefinition of its corporate identity and growth strategy.
-
Average Daily Trading Volume: 83,535
-
Technical Sentiment Signal: Sell
-
Current Market Capitalization: £1.04 million
CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).
This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Ltd. ADVFN Ltd does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.